Welcome to the Journal
h5-index citation: 9
NLM ID: 101562294
5 Years Journal Impact Factor = 1.578*
Journal of Diabetes management is peer-reviewed, open access journal that publishes original and high-quality research papers in all areas which is related to Diabetes
It is an open access and online journal that offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field. Each individual article is peer reviewed and approved for publication by eminent scientists in the field of Diabetology. The journal maintains the highest standards in terms of quality of content published. In addition to Research Articles, the Journal also publishes high quality Commentaries, Reviews, Perspectives, and Case Reports.
Journal of Diabetes management is a medical journal that covers wide areas of studies in this field by including type 1 and type 2 diabetes, Glucose regulation, glucose metabolism, Glucose Homeostasis Insulin function, High blood pressure, Diabetes therapy, Pediatric Diabetes, Pre Diabetes, Endocrinology, Diabetic Medicine, Endo and Exocrine Pancreatic Defects, Detection and Prevention of Hypo and Hyperglycemia, Carbohydrate metabolism, Diabetes Classification, Metabolic Disorders, Cell Therapy for Diabetes, laboratory research, Impaired Glucose Tolerance, Insulin Resistance, Insulin Therapy, Diabetes, Obesity and Metabolism, Diabetes and Vascular Disease, Diabetes Nursing, Diabetes studies, A1C Test, Gestational Diabetes, Research in pancreatic islets, Diabetic complications such as Cardiovascular and Metabolic Risk, Heart diseases (Cardiac failure), Congenital Heart Disease, Diabetic neuropathy, Diabetic nephropathy-Renal failure and impotence, Retinopathy, Therapies for Diabetic Complications.
The journal encourages broader research perspectives including Clinical Care, Education and Nutrition to fight diabetes. The journal also focuses on aspects involving Psychosocial Research, Epidemiology, Health Services Research on Emerging Treatments and Technologies to deal with Pathophysiology, Complications, Cardiovascular and Metabolic Risk.
Fast Editorial Execution and Review Process (FEE-Review Process):
Diabetes Management is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
INDEXING: EMBASE, Excerpta Medica, CAS (Chemical Abstracts Service), EMCare, Open J Gate,CNKI
Recently Published Articles
Commentary p. 524-525
Author(s): Cecilia Low
Commentary p. 522-523
GLP-1 receptor agonists and their role in diabetes management: Benefits, considerations and side effects
Author(s): Dalia Somjen
Perspective p. 520-521
Author(s): Jarir Thobari
Research Article p. 542-547
Changes in peripapillary microvasculature and retinal thickness in the fellow eyes of patients with unilateral retinal vein occlusion: An OCTA study
Author(s): Ahmed Shahin*, Tarek Tawfik Soliman, Soha Moussa Tohamy, Ibrahim Abd EL Khalek El Saadani
Background: Retinal Vein Occlusion (RVO) is the second most common retinal vascular disease following diabetic retinopathy and is a frequent cause of significant visual loss and associated m..